Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Patient feedback after surgery may cut opioid misuse by half

NCT ID NCT07659730

Disease control Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a structured follow-up program after surgery can reduce the number of people still using opioids 90 days later. The program uses patient-reported recovery scores to guide care, with nurses and community providers working together. About 772 adults having surgery at participating hospitals will be randomly assigned to this enhanced follow-up or usual care. The goal is to see if this approach lowers persistent opioid use and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured hospital-community follow-up with patient-reported outcome measures
What this could lead to
If successful, this approach could significantly reduce the number of people who continue using opioids long after surgery, lowering the risk of addiction and side effects.
What could go wrong
This is a pragmatic trial building on earlier promising results, but the effect may be smaller in a larger, more diverse population. The intervention requires coordination between hospitals and community providers, which may be challenging to implement consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 772 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * Adult patient, with no upper age limit * Undergoing scheduled or unscheduled surgery in a center participating in the research * Subject affiliated to a social health insurance scheme * Subject able to understand the objectives and risks related to the research and to give informed consent, dated and signed Exclusion Criteria: * Inability to administer the mQoR-15f questionnaire (cognitive disorders, language barrier) * Patient who has already received previous follow-up by the OPTIMISTE team * Patient enrolled in a therapeutic trial that may affect post-operative recovery quality. * Pregnant or breastfeeding woman * Inability to provide the subject with informed information (subject in an emergency situation, difficulties in understanding, etc.) * Subject under legal protection, guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perioperatoire medicine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perioperatoire medicine Surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.